Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Radiosurgery × Tumor-Agnostic × Clear all

Phase

Status

Recruiting 7 Completed 7 Unknown 3 Withdrawn 2 Terminated 2 Active not recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 14 Genitourinary 9 Thoracic 6 Breast 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Head & Neck 1 CNS 1

Conditions

Neoplasm Metastasis 1

Interventions

Standard of Care 3 Oxaliplatin 3 tislelizumab 2 pembrolizumab 2 cemiplimab 2 Radiotherapy 2 Radiation 2 Paclitaxel 2 Data Collection 2 Capecitabine 2 trastuzumab deruxtecan 1 trametinib 1 toripalimab 1 surufatinib 1 sintilimab 1 monalizumab 1 coenzyme Q10 1 blinatumomab 1 anlotinib 1 Whole Genome Sequencing 1 Ursodeoxycholic Acid 1 Ultrasonography 1 Thymopentin 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sequence Analysis, RNA 1 Respiratory Rate 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Psychosocial Intervention 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06363773 2024-08-28

RESTO-IMMUNO

Elsan

Phase NA Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡